Fluorescent PCR primer group for specifically recognizing TYGPVFMSL peptide fragment and application thereof
A primer set and specific technology, applied in the field of genetic engineering, can solve problems such as undiscovered
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Example 1 Primer Design
[0026] According to HLAA24 typing, TCR primer pairs were designed at the L24-3, L24-5 and L24-13 sites of the EBV virus antigen peptide TYGPVFMSL, and the sequences of the obtained primer pairs are shown in SEQ ID NO.1-6.
Embodiment 2
[0027] Embodiment 2 standard curve is established
[0028] Take the L24-3 site of TCR as an example to design the scheme.
[0029] Take 10 of the plasmid DNA standard at the L24-3 site 8 copy number dilution, 10 7 copy number dilution, 10 6 copy number dilution, 10 5 copy number dilution, 10 4 copy number dilution, 10 3 copy number dilution, 10 2 copy number dilution, 10 1 copy number dilutions, and set up real-time fluorescent PCR according to the following reaction system and reaction procedures.
[0030] Reaction system: PCR master mix 10 μl; forward primer 0.4 μl, primer concentration: 10 μm / μl; reverse primer 0.4 μl, primer concentration: 10 μm / μl; ROX Reference Dye (50×) 0.2 μl; TCR-T cell drug Genomic DNA 2μl, concentration 50ng / μl, or TCR plasmid standard DNA 2μl; Nuclease-Free Water 7μl; total reaction system 20μl.
[0031] PCR reaction program: 95°C, 30s; (95°C, 5s; 60°C, 20s) 40 cycles. Set the reference fluorescence to ROX, select the reaction type as SYB...
Embodiment 3
[0035] Embodiment 3 Sensitivity detection
[0036] The genomic DNA stock solution, 10-fold dilution, 100-fold dilution, 1000-fold dilution, and 10000-fold dilution of the TCR-T cell drug directed at the L24-3 site, according to the reaction system and program of real-time fluorescent PCR in Example 2 Amplify. Obtain the amplification curve of the genomic DNA of the TCR-T cell drug directed at the L24-3 site as Figure 4 shown. The amplified products were subjected to agarose gel electrophoresis, and the results were as follows: Figure 5 shown.
[0037] Substitute the obtained Ct value of the genomic DNA of each dilution of the TCR-T cell drug into the standard curve in Example 2, and the copy number of the genomic DNA of each dilution of the TCR-T cell drug can be calculated.
[0038] After calculation, the copy number of the TCR-T cell drug genomic DNA stock solution targeting the L24-3 site is 27423 copies, the copy number of the 10-fold dilution is 3064 copies, and the...
PUM
![No PUM](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/noPUMSmall.5c5f49c7.png)
Abstract
Description
Claims
Application Information
![application no application](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/application.06fe782c.png)
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap